GENEVA, July 9 -- SPROUT PHARMACEUTICALS, INC. filed a patent application (IB2026/050020) for “TREATMENT OF SEXUAL DESIRE DISORDERS IN PATIENTS TREATED WITH GLP-1 AGONISTS AND RELATED AGENTS”. With publication no. WO/2026/146455, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4184
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....